News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
May, 2025
May 2025
M T W T F S S
 1234
567891011
12131415161718
19202122232425
262728293031  
Rahul Banerjee: CEPHEUS by Saad Z. Usmani, et al is out
Rahul Banerjee and Saad Z. Usmani
Feb 7, 2025, 08:39

Rahul Banerjee: CEPHEUS by Saad Z. Usmani, et al is out

Rahul Banerjee, Assistant professor at Fred Hutchinson Cancer Center at the University of Washington, shared an article by Saad Z. Usmani, et al. on X:

“CEPHEUS out!

Congratulations Saad Z. Usmani, et al.

PFS with quad in ASCT MMsm. Nice discussion of similarities (many) & differences (few) vs IMROZ.

CD38-VRd now the norm for many: time to shift algorithms to quad-eligible vs not regardless of ASCT plans!”

Daratumumab plus bortezomib, lenalidomide and dexamethasone for transplant-ineligible or transplant-deferred newly diagnosed multiple myeloma: the randomized phase 3 CEPHEUS study.

Authors: Saad Z. Usmani, et al.

Rahul Banerjee: CEPHEUS by Saad Z. Usmani, et al is out

Bortezomib cancer CD38-VR CEPHEUS Daratumumab dexamethasone fight against cancer Fred Hutchinson Cancer Center Global fight against cancer IMROZ Lenalidomide multiple myeloma OncoDaily Oncology Rahul Banerjee Saad Z. Usmani University of Washington
Special Coverage
Science
May 9, 2025, 08:02
Ashish Kamat: Predictive Value of AI Histologic Biomarker CHAI in NMIBC Treatment
Drugs
May 9, 2025, 07:54
Rahul Banerjee: Financial Toxicity Is the First Side Effect of Lenalidomide in Multiple Myeloma
Blog
May 9, 2025, 07:41
Eric Singhi: First-Year Fellow’s Graduation from the Singhi Clinic
Science
May 9, 2025, 07:24
Elizabeth McKenna: Study on Early- and Older-Onset Cancer Trends in the U.S. by Meredith Shiels and colleagues
Drugs
May 9, 2025, 07:19
Jenny Seligmann: FOxTROT 5 Opens in the UK – New immunotherapy trial for older colon cancer patients
Career
May 9, 2025, 07:02
Vinay Prasad Appointed as the New Head of FDA's Center for Biologics Evaluation and Research
Blog
May 9, 2025, 06:47
Wade Swenson: Addressing the rural cancer care crisis in Minnesota requires innovative solutions
Oncolibrary
May 9, 2025, 06:27
Understanding Neoplasms: What They Are, Types, Causes, and How They’re Treated
Insight
May 9, 2025, 06:07
Oguna Kasam: Landmark Achievement for Kenya - Aga Khan University Hospital Delivered First Lutetium 177 Therapy
Drugs
May 9, 2025, 05:39
Erika Hamilton: Zanidatamab Combination Shows Promising Results in HR+/HER2+ Metastatic Breast Cancer
Science
May 9, 2025, 04:20
Valerie Yang: What started out as an academic collaboration is now available as a treatment option for soft tissue sarcoma patients
Cancer Types
May 9, 2025, 02:44
Medulloblastoma: Breakthroughs in Types, Symptoms, Diagnosis, Treatment, and 2025 Advances in Care